Venture Capital: The Mature Years
Executive Summary
The maturation of the medical industry proceeds apace and with it the venture capital industry, which, paradoxically, is turning into a mature asset class. VCs don't generally recognize this--but will have to adapt their strategies to this changing reality.
You may also be interested in...
In Tough Times, VCs Go Late-Stage
Tough times in the investment business are as likely to cause unreasonably conservative behavior as much as good times might drive irrational exuberance. But for VCs, the new conservatism threatens their essential advantage as investors.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.